1. Reduced efficacy of ivermectin and moxidectin against Parascaris spp. in foals from Argentina.
- Author
-
Cooper LG, Caffe G, Cerutti J, Nielsen MK, and Anziani OS
- Subjects
- Animals, Argentina, Ascaridida Infections drug therapy, Ascaridida Infections parasitology, Female, Horse Diseases parasitology, Horses, Male, Antinematodal Agents therapeutic use, Ascaridida Infections veterinary, Ascaridoidea drug effects, Horse Diseases drug therapy, Ivermectin therapeutic use, Macrolides therapeutic use
- Abstract
Macrocyclic lactones are the most widely used drugs for the control of gastrointestinal nematodes of horses in Argentina. Ivermectin and moxidectin are used as broad spectrum anthelmintics and although there are several international reports on the resistance of Parascaris spp., the resistance status of the local nematode population is largely unknow. This report informs a case of suboptimal efficacy to both drugs to control Parascaris spp in foals in central Argentina. In February 2018, routine fecal parasite egg counts showed a moderate-high number of Parascaris spp eggs (mean = 680 eggs per gram of feces) in foals treated approximately one month before with moxidectin. Upon suspicion of resistance of this parasite to the macrocyclic lactones, 24 of these animals were selected for a fecal egg count reduction test (FECRT). Twelve foals were treated with ivermectin and the remaining 12 animals with moxidectin. Two weeks after treatment, the FECRT was 48.1% and 34.8% for moxidectin and ivermectin respectively (25% of the animals increased the number of eggs in feces after treatment). Five days later, the administration of fenbendazole resulted in a FECRT = 100%. The monitoring of the status of susceptibility or resistance in each establishment is critical for the design of control programs based on rational and sustainable use of anthelmintics., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF